Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
SeraNovo has signed a second License Agreement with Carna Biosciences.
read more
Cipla Limited announced its submission of an ANDA for Fluticasone propionate and Salmeterol inhalation powder (100/50 mcg, 250/50 mcg and 500/50 mcg) to the FDA.
read more
Mylan announced a global collaboration with Gilead Sciences to expand access to the investigational antiviral remdesivir for the potential treatment of COVID-19.
read more
Sterling Pharma Solutions has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19.
read more
In response to scammers on the internet selling unproven medical products, the FDA has taken a number of steps to find and stop those selling unapproved products that fraudulently claim to mitigate, prevent, treat, diagnose or cure COVID-19.
read more
HCATS and apceth Biopharma have expanded their relationship with bluebird bio with long-term development and manufacturing services agreements for clinical and commercial supply for multiple therapies.
read more
Humanigen has dosed the first COVID-19 patient in its study for lenzilumab, the company’s GM-CSF monoclonal antibody.
read more
AMRI has announced its ongoing commitment to do its part in support of public health needs amidst the COVID-19 pandemic.
read more
Wednesday, April 29, 2020
A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials has been announced by Quotient Sciences and CytoAgents.
read more
Avet Pharmaceuticals is initiating a voluntary recall of the following lots of Tetracycline HCl Capsules USP, 250 mg and 500 mg, 100-count bottles.
read more
MilliporeSigma and The Jenner Institute announced The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
read more
The FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the COVID-19 pandemic.
read more
Wednesday, April 15, 2020
Immunoprecise Antibodies announced has entered into a research license agreement with Janssen Research & Development.
read more
Mylan Chairman Robert J. Coury and Chief Executive Officer Heather Bresch provided additional detail regarding the company's efforts to meet public health needs amid the evolving COVID-19 pandemic.
read more
Samsung Biologics entered into a strategic partnership with PharmAbcine for the development and manufacturing of PMC-402 pipeline.
read more